Table 1.
Baseline data of enrolled patients.
| All patients | Not admitted to the ICU | Admitted to the ICU | ||
|---|---|---|---|---|
| Variable | N = 100 | N = 88 | N = 12 | p Value |
| Sex (male, n(%)) | 59.00 (59.00%) | 49.00 (55.68%) | 10.00 (83.33%) | .12 |
| Age (years, mean ± SD) | 65.77 ± 12.75 | 65.03 ± 12.87 | 71.17 ± 10.84 | .16 |
| BMI (kg/m², mean ± SD) | 21.98 ± 3.19 | 22.09 ± 3.17 | 21.18 ± 3.35 | .50 |
| Height (cm, mean ± SD) | 166.14 ± 8.24 | 165.90 ± 8.38 | 167.92 ± 7.13 | .41 |
| Weight (kg, mean ± SD) | 61.10 ± 12.17 | 61.25 ± 12.29 | 60.04 ± 11.72 | .92 |
| turn-NE-day (day, mean ± SD) | 16.56 ± 8.39 | 16.06 ± 7.76 | 20.25 ± 11.83 | .54 |
| Exacerbation time (day) | / | / | 9.08 | / |
| COVID-19 class | <.01 | |||
| Mild disease | 88.00 (88.00%) | 88.00 (100%) | 0.00 (0.00%) | |
| Severe disease | 11.00 (11.00%) | 0.00 (0.00%) | 11.00 (91.67%) | |
| Critical disease | 1.00 (1.00%) | 0.00 (0.00%) | 1 (8.33%) | |
| Vaccinated, n(%) | 6 (6%) | 5 (5.68%) | 1.00 (8.33%) | .58 |
| HBP, n(%) | 86.00 (86.00%) | 76.00 (86.36%) | 10.00 (83.33%) | .67 |
| DM, n(%) | 33.00 (33.00%) | 26.00 (29.55%) | 7.00 (58.33%) | .06 |
| Polycysticliver, n(%) | 7.00 (7.00%) | 6.00 (6.82%) | 1.00 (8.33%) | .85 |
| HBV, n(%) | 3.00 (3.00%) | 3.00 (3.41%) | 0.00 (0.00%) | .52 |
| HCV, n(%) | 2.00 (2.00%) | 2.00 (2.27%) | 0.00 (0.00%) | .60 |
| Liver cirrhosis, n(%) | 3.00 (3.00%) | 2.00 (2.27%) | 1.00 (8.33%) | .25 |
| Manifestation | ||||
| Fever, n(%) | 14.00 (14.00%) | 12.00 (13.64%) | 2.00 (16.67%) | .78 |
| Throatpain, n(%) | 16.00 (16.00%) | 13.00 (14.77%) | 3.00 (25.00%) | .36 |
| Cough, n(%) | 45.00 (45.00%) | 40.00 (45.45%) | 5.00 (41.67%) | .8 |
| Expectoration, n(%) | 27.00 (27.00%) | 22.00 (25.00%) | 5.00 (41.67%) | .22 |
| Dyspnea, n(%) | 36.00 (36.00%) | 27.00 (30.68%) | 9.00 (75.00%) | <.01 |
| Orthopnea, n(%) | 5.00 (5.00%) | 2.00 (2.27%) | 3.00 (25.00%) | .01 |
| Edema, n(%) | 8.00 (8.00%) | 6.00 (6.82%) | 2.00 (16.67%) | .24 |
| Nausea, n(%) | 13.00 (13.00%) | 11.00 (12.50%) | 2.00 (16.67%) | .69 |
| Vomit, n(%) | 7.00 (7.00%) | 6.00 (6.82%) | 1.00 (8.33%) | .85 |
| Anorexia, n(%) | 3.00 (3.00%) | 2.00 (2.27%) | 1.00 (8.33%) | .25 |
| Diarrhea, n(%) | 2.00 (2.00%) | 2.00 (2.27%) | 0.00 (0.00%) | .6 |
| Hematemesis, n(%) | 3.00 (3.00%) | 0.00 (0.00%) | 3.00 (25.00%) | <.01 |
| Conscious | <.01 | |||
| Clear-headed state, n(%) | 93.00 (93.00%) | 86.00 (97.73%) | 7.00 (58.33%) | |
| Somnolence state, n(%) | 5.00 (5.00%) | 2.00 (2.27%) | 3.00 (25.00%) | |
| Coma, n(%) | 2.00 (2.00%) | 0.00 (0.00%) | 2.00 (16.67%) |
Note: ICU: Intensive care unit; SD: standard deviation; BMI: body mass index; turn-NE-day: days of nucleic acid turning negative after COVID-19 infection; HBP: hypertension; DM: diabetes mellitus; HBV: hepatitis B virus; HCV: hepatitis C virus.
The boldface represent that the p value of these variables was less than 0.05, indicating that there was a statistical difference between the two groups.